Cargando…
The revision of the pharmaceutical legislation — it is time to act for nuclear medicine in Europe
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684671/ https://www.ncbi.nlm.nih.gov/pubmed/37867178 http://dx.doi.org/10.1007/s00259-023-06472-1 |
| _version_ | 1785151455810813952 |
|---|---|
| author | Patt, Marianne Decristoforo, Clemens de Martini, Amélie Koole, Michel Oyen, Wim J. G. Kiss, Oliver C. |
| author_facet | Patt, Marianne Decristoforo, Clemens de Martini, Amélie Koole, Michel Oyen, Wim J. G. Kiss, Oliver C. |
| author_sort | Patt, Marianne |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10684671 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106846712023-11-30 The revision of the pharmaceutical legislation — it is time to act for nuclear medicine in Europe Patt, Marianne Decristoforo, Clemens de Martini, Amélie Koole, Michel Oyen, Wim J. G. Kiss, Oliver C. Eur J Nucl Med Mol Imaging Editorial Springer Berlin Heidelberg 2023-10-23 2023 /pmc/articles/PMC10684671/ /pubmed/37867178 http://dx.doi.org/10.1007/s00259-023-06472-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Editorial Patt, Marianne Decristoforo, Clemens de Martini, Amélie Koole, Michel Oyen, Wim J. G. Kiss, Oliver C. The revision of the pharmaceutical legislation — it is time to act for nuclear medicine in Europe |
| title | The revision of the pharmaceutical legislation — it is time to act for nuclear medicine in Europe |
| title_full | The revision of the pharmaceutical legislation — it is time to act for nuclear medicine in Europe |
| title_fullStr | The revision of the pharmaceutical legislation — it is time to act for nuclear medicine in Europe |
| title_full_unstemmed | The revision of the pharmaceutical legislation — it is time to act for nuclear medicine in Europe |
| title_short | The revision of the pharmaceutical legislation — it is time to act for nuclear medicine in Europe |
| title_sort | revision of the pharmaceutical legislation — it is time to act for nuclear medicine in europe |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684671/ https://www.ncbi.nlm.nih.gov/pubmed/37867178 http://dx.doi.org/10.1007/s00259-023-06472-1 |
| work_keys_str_mv | AT pattmarianne therevisionofthepharmaceuticallegislationitistimetoactfornuclearmedicineineurope AT decristoforoclemens therevisionofthepharmaceuticallegislationitistimetoactfornuclearmedicineineurope AT demartiniamelie therevisionofthepharmaceuticallegislationitistimetoactfornuclearmedicineineurope AT koolemichel therevisionofthepharmaceuticallegislationitistimetoactfornuclearmedicineineurope AT oyenwimjg therevisionofthepharmaceuticallegislationitistimetoactfornuclearmedicineineurope AT kissoliverc therevisionofthepharmaceuticallegislationitistimetoactfornuclearmedicineineurope AT pattmarianne revisionofthepharmaceuticallegislationitistimetoactfornuclearmedicineineurope AT decristoforoclemens revisionofthepharmaceuticallegislationitistimetoactfornuclearmedicineineurope AT demartiniamelie revisionofthepharmaceuticallegislationitistimetoactfornuclearmedicineineurope AT koolemichel revisionofthepharmaceuticallegislationitistimetoactfornuclearmedicineineurope AT oyenwimjg revisionofthepharmaceuticallegislationitistimetoactfornuclearmedicineineurope AT kissoliverc revisionofthepharmaceuticallegislationitistimetoactfornuclearmedicineineurope |